WaferGen, Qiagen Japan Pact to Focus on High-Throughput Biomarker Validation, Eventually NGS | GenomeWeb

WaferGen Biosystems said this week that it has inked a co-marketing agreement with Qiagen KK, Qiagen's Japanese subsidiary, to jointly promote WaferGen's SmartChip Real-Time PCR system and consumable chips with Qiagen's PCR assays and, eventually, sequencing products.

For WaferGen, the agreement is a "big milestone" in that it is its first agreement with a "bona fide" commercial partner, and provides the company with access to a geographic market it previously did not inhabit, CEO Ivan Trifunovich told PCR Insider this week.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.